HomeInvestingEarningsModerna (MRNA) CFO on Earnings & Covid Vaccine Sales

Moderna (MRNA) CFO on Earnings & Covid Vaccine Sales

Moderna (MRNA) expects regulatory approval for its investigational RSV vaccine for older adults starting in 1H24. Moderna CFO Jamey Mock discusses 4Q earnings, as well as Covid vaccine sales. Moderna has reaffirmed its 2024 product sales outlook. Tune in to find out more about the stock market today.

Market On Close

22 Feb 2024

SHARE

ON AIR
1:00 pm
The Watch List
12:00 am
Fast Market
REPLAY
1:00 am
Next Gen Investing
REPLAY
2:00 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:30 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
5:30 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
ON AIR
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Gamma On
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Gamma On
REPLAY
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor